Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
385 News Items found
Kirt Robinson
In the Clinic
Kirt’s Story: How a Clinical Trial for a Rare Tumor Gave Me a New Lease on Life

A clinical trial led by MSK sarcoma expert Mrinal Gounder has shown promising results for treating desmoid tumors.
Illustration of mechanical arms altering a cell
In the Lab
MSK Scientists Fine-Tune CAR T Cells to Improve Their Performance

The updated versions can survive longer in the body while still packing a punch against cancer.
MSK internal medicine specialist Deborah Korenstein
Q&A
Helping Doctors "Do No Harm" by Addressing Medical Test Overuse

Learn how MSK is clarifying how unnecessary medical tests can harm a patient's well-being.
a cabinet full of yellow rubber duckies and one blue one
In the Lab
The Immune System Can Fight Cancer. So Why Doesn’t It?

New research from scientists at the Sloan Kettering Institute helps explain how growing tumors escape our immune defenses.
Image of dividing breast cancer cells taken with electron microscope.
In the Lab
Researchers Identify Why Women May Develop Resistance to a New Class of Breast Cancer Drugs

Clues emerge about why promising new breast cancer drugs sometimes don’t work — and what might be done about it.
Andrea Barrio (right) and fellow Shirin Muhsen focus on surgery for breast cancer.
In the Clinic
Sessions at Annual Breast Cancer Conference Focus on Prevention and Treatment of Lymphedema

Experts from Memorial Sloan Kettering presented some of the latest research on this challenging complication of many cancer surgeries.
ASH meeting signage
Roundup
Advances in Myeloma, Lymphoma, and Bone Marrow Transplant Announced at the 2018 ASH Meeting

Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology.
Jonathan Peled speaks during a press conference
Finding
Gut Microbes May Protect People Having Bone Marrow Transplants

For the first time, researchers have found an association between the makeup of the microorganisms in the body before a bone marrow transplant and a patient’s survival afterward.
scientific image
In the Clinic
Personalized Medicine 2.0: MSK Leads the Way in the Study of Drug Resistance in Lung Cancer

Overcoming resistance to drug treatment for lung cancer is a critical challenge.
A tube of blood superimposed on a lung and a DNA helix
In the Clinic
Liquid Biopsy Is Effective at Guiding Treatment of Lung Cancer, Study Finds

The initial results of an ongoing study show that a liquid biopsy has advantages over a tissue biopsy for people with lung cancer.